China Pharma (NYSE:CPHI) Upgraded to Hold at StockNews.com

China Pharma (NYSE:CPHI) was upgraded by research analysts at StockNews.com from a “sell” rating to a “hold” rating in a report issued on Wednesday.

China Pharma Trading Up 8.8%

Shares of CPHI opened at $2.35 on Wednesday. China Pharma has a 52 week low of $1.20 and a 52 week high of $3.39. The stock’s 50-day moving average price is $11.48 and its 200-day moving average price is $17.66. The company has a debt-to-equity ratio of 0.22, a quick ratio of 0.26 and a current ratio of 0.79.

China Pharma Company Profile

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.